^
Association details:
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Title:

CS-PEI/Beclin-siRNA Downregulate Multidrug Resistance Proteins and Increase Paclitaxel Therapeutic Efficacy against NSCLC

Excerpt:
Compared with NCI-H23, NCI-H23-TXR had higher expression levels in P-glycoprotein (P-gp) and multidrug resistance protein 7 (ABCC10).
DOI:
10.1016/j.omtn.2019.06.017